July 27 2022
Sue Yom, MD from UCSF, gave an oral presentation about the translational analysis of blood specimens for NRG-HN002, a study of (chemo)radiation treatment for 306 patients with stage I HPV+ oropharyngeal cancer. Click here to listen to the interview.
NRG-GI008 (CIRCULATE-US)Arvind Desari, MD from MD Anderson Cancer Center, led a Trials in Progress poster discussion about NRG-GI008. This study is designed to determine whether chemotherapy is needed and if so, what kind to recommend to patients based on the presence or absence of ctDNA after surgery for colon cancer. Click here to listen to the interview.